Luigi Mangione's lawyers abruptly withdrew his psychiatric defense Thursday, one day after announcing it — but the rage at a healthcare system that bleeds working Americans while executives cash in isn't going anywhere near a courtroom, and that's the story that matters most to your paycheck.
Mangione, 28, faces state murder and federal stalking charges for the Dec. 4, 2024, shooting of UnitedHealthcare CEO Brian Thompson outside the company's annual investor conference in Manhattan. His lawyers told Judge Gregory Carro on Wednesday they planned to argue "extreme emotional disturbance" — a defense that under New York law could have reduced a murder charge to manslaughter, cutting a potential life sentence to 25 years max. By Thursday, attorney Karen Friedman Agnifilo sent a one-sentence letter "respectfully withdrawing" the notice.
The reversal came the same day as a deadline to hand prosecutors medical records supporting the claim. The New York Post reported defense attorney Ron Kuby speculated the withdrawal may have been a move to avoid turning over those records, noting Mangione's team can still argue extreme emotional disturbance at trial — just without calling mental health experts or introducing psychiatric evidence.
At Wednesday's hearing, Agnifilo protested Carro's decision to unseal materials related to the psychiatric defense, warning it would be "prejudicial to his defense to the exact same facts" in his federal case, where the emotional disturbance defense isn't available.
Carro has already ruled that a 3D-printed gun matching the murder weapon and a notebook police say links Mangione to the killing are admissible. Prosecutors say the diary describes wanting to "wack the CEO at the annual parasitic bean-counter convention" and calls it "targeted, precise, and doesn't risk innocents." It also describes rebelling against what it calls "the deadly, greed fueled health insurance cartel."
Ammunition at the scene bore the words "delay," "deny" and "depose" — a direct reference to the playbook insurers use to avoid paying claims. That detail, noted by the Guardian and Baltimore News, cuts to the heart of why this case struck a nerve. NBC News reported Thompson's killing "unleashed a torrent of hostility toward the industry."
Here's why that matters beyond the courtroom: UnitedHealthcare is the country's largest health insurer. Thompson, 50, was gunned down walking to an investor conference — not a patient care summit. The company rakes in premium dollars from working Americans, then deploys the delay-and-deny tactics Mangione's ammunition literally spelled out. Meanwhile, UnitedHealth Group executives and shareholders gather at hotel conferences to celebrate returns.
The Post framed the defense withdrawal as "bizarre." The other outlets stuck to straight legal process. None of them lingered on the economics. But the economic reality is the backdrop the public understands intuitively: Americans pay more for healthcare than any other developed nation and get worse outcomes. Insurance monopolies extract wealth from the middle and working class while enjoying antitrust exemptions and regulatory capture that would make the railroads blush. When both parties in Washington take donations from the same industry and deliver the same result — higher premiums, higher deductibles, denied claims — the bipartisan failure isn't subtle.
Mangione's state trial starts Sept. 8; his federal trial Oct. 13. He has pleaded not guilty. Whatever the verdict, the cartel he wrote about will keep operating.
The open question isn't whether one man is guilty. It's whether the system that made him a folk hero to some Americans faces any accountability of its own.
